Parsabiv™ (etelcalcetide) is indicated for the treatment of secondary hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKD) on hemodialysis.

Parsabiv™ has not been studied in adult patients with parathyroid cancer, primary hyperparathyroidism, or with CKD who are not on hemodialysis and should not be used in these patients.

Read More

An IV treatment that lowers and maintains all 3 sHPT lab values1

IV = intravenous; sHPT = secondary hyperparathyroidism.

What is sHPT?

When your kidneys fail, your parathyroid glands can make too much parathyroid hormone (PTH)2,3


Too much PTH can make your phosphorus and calcium levels go up4-6

What’s the goal?

Your dialysis care team may have goal ranges for your PTH, phosphorus, and calcium levels.

Parsabiv™ is part of their plan to get and keep your levels in range.


P = phosphorus; Ca = calcium.

Why did my doctor prescribe Parsabiv™?

It’s a treatment for secondary HPT in adult patients with chronic kidney disease (CKD) on hemodialysis1

Parsabiv™ (etelcalcetide) acts on your parathyroid glands and causes them to release less PTH1


When PTH goes down, your bones release less phosphorus and calcium.4,5

One treatment that can help lower the 3 key levels1

Your doctor may also prescribe other medicines to treat your secondary HPT:

  • Phosphate binders* help you absorb less phosphorus from the food you eat4
  • Certain types of vitamin D* may help lower your PTH. This medicine is usually given to you through the dialysis machine, or you may take it as a pill3,7


*Phosphate binders and vitamin D are available by prescription.
HPT = hyperparathyroidism.

How will Parsabiv™
be given to me?

Parsabiv™ is given at the end of your hemodialysis session, three times a week, through the tube (bloodline) that connects you to the machine1

IV delivery means your nurse or other healthcare provider will administer it for you





Keep in mind: You shouldn’t be started on Parsabiv™ if you have low calcium levels. (You can ask your doctor about normal ranges for calcium.)1


Pill shown is not actual size

What are possible
side effects?

You may experience side effects while taking Parsabiv™(etelcalcetide)1

Some patients reported potential symptoms of a condition called hypocalcemia (low calcium levels), including spasms, twitches, or cramps in your muscles; numbness or tingling in your fingers, toes, or around your mouth; or seizures.

During studies of Parsabiv™, some patients reported other various side effects like diarrhea, nausea, and vomiting.

What if I feel
side effects?

Talk to your heathcare provider right away.

After talking to your healthcare provider, you can report negative side effects of prescription drugs to the FDA.

Visit or call
1-800-FDA-1088 (332-1088).


FDA = Food and Drug Administration.

What if my dialysis care team is switching me from Sensipar® (cinacalcet) to Parsabiv™?

Stop taking Sensipar® for at least 7 days before you start Parsabiv™(etelcalcetide)

You need to stop taking Sensipar® tablets at least 7 days before you can start Parsabiv™. You cannot be on both drugs at the same time.1

chart chart

Keep in mind: You shouldn’t be started on Parsabiv™ if you have low calcium levels. (You can ask your doctor about normal ranges for calcium.)


Pills shown are not actual size

Is there
coverage support 
for Parsabiv™?

Amgen Assist® offers comprehensive
coverage assistance

You may have out-of-pocket costs for Parsabiv™, like a co-pay or co-insurance. Depending on your circumstances, there may be programs that can help if you are having difficulty affording your medications.

Amgen Assist

For more information about coverage of Parsabiv™, talk to your social worker—or contact Amgen Assist® at 1-800-272-9376